Connor, Daniel F.Benjamin, SheldonOzbayrak, Kaan R.2022-08-232022-08-231995-11-012011-03-28J Am Acad Child Adolesc Psychiatry. 1995 Nov;34(11):1490-4. <a href="http://dx.doi.org/10.1097/00004583-199511000-00016">Link to article on publisher's website</a>0890-8567 (Linking)10.1097/00004583-199511000-000168543517https://hdl.handle.net/20.500.14038/45931Risk factors for neuroleptic withdrawal dyskinesia in children have not been well studied. The authors present a case of a child who had been treated with a combination of neuroleptics and stimulants for nonpsychotic aggressive behavior. A severe withdrawal dyskinesia precipitated by neuroleptic tapering was ameliorated by discontinuation of the psycho-stimulant. Although stimulants have been reported to increase certain involuntary movement disorders, this is the first known report of psychostimulant exacerbation of withdrawal dyskinesia.en-USAntipsychotic AgentsDextroamphetamineDiphenhydramineFluoxetineHumansMaleMental DisordersMovement DisordersPerphenazinePsychiatric Status Rating ScalesSubstance Withdrawal SyndromeVideotape RecordingPsychiatryCase study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatmentJournal Articlehttps://escholarship.umassmed.edu/psych_pp/4571905660psych_pp/457